top of page
chapters_Cognitive Disorder .jpg

Cognitive Disorder and Dementia

other cognitive symptoms such as difficulty in execution and language
ABOUT THIS CONDITION

Cognitive disorders—such as mild cognitive impairment (MCI) and dementia—are common in older adults and can affect memory, thinking, behaviour, and daily functioning. These conditions have many underlying causes, most commonly Alzheimer’s disease (AD), and often place a significant burden on individuals, families and carers. Early and accurate diagnosis is increasingly important as new disease‑modifying treatments become available.

•	Alzheimer’s disease and other neurodegenerative diseases causing cognitive impairment
OUR APPROACH

Our Chapter brings together geriatricians, neurologists, neuroradiologists, neurosurgeons, pathologists, clinical psychologists, and nurses to provide comprehensive evaluation of patients, optimal treatments and close monitoring of treatment outcome including adverse effects.

This team works jointly to support people with:

 

  • memory decline

  • other cognitive symptoms such as difficulty in execution and language

  • behavioural and psychological symptoms of dementia e.g. anxiety, depression, agitation, aggression

  • Alzheimer’s disease and other neurodegenerative diseases causing cognitive impairment

 

By combining clinical expertise and coordinated care, we aim to support better understanding, earlier detection and better‑informed management decisions for people with cognitive disorders and dementia.

INTEGRATING CARE AND RESEARCH

Clinical experience and research developments facilitate one another throughout this Chapter’s work.

Current programmes include:

 

  • Development and validation of blood biomarkers for earlier and more accurate diagnosis in local populations

  • Advanced neuroimaging research to understand disease progression and monitor treatment response in Alzheimer’s disease

  • Exploration of non‑invasive neurostimulation techniques, such as transcranial pulse stimulation, as potential treatment options

  • Coordination of care for AD patients receiving anti‑amyloid therapies, supported by multidisciplinary monitoring of treatment outcomes and adverse effects

 

This approach helps to ensure that emerging evidence, technologies and diagnostic tools benefit patient care.

memory decline
OUR TEAM

Chapter Lead

Professor Koon Ho Chan

Clinical Professor, Henry G Leong Professor in Neurology, Department of Medicine, School of Clinical Medicine, HKUMed

Honorary Consultant, Department of Medicine, Queen Mary Hospital, Hong Kong

Key Member

Professor Michael Häusser 

Director, School of Biomedical Sciences, HKUMed 

Key member

Dr Yat Fung Shea

Consultant Geriatrician, Department of Medicine, Queen Mary Hospital, Hong Kong

 

Honorary Clinical Associate Professor, Department of Medicine, School of Clinical Medicine, HKUMed

Key member

Dr Ka Chun Chiu

Consultant Geriatrician, Department of Medicine, Queen Mary Hospital, Hong Kong

 

Honorary Clinical Associate Professor, Department of Medicine, School of Clinical Medicine, HKUMed

Key member

Professor Henry KF Mak

Clinical Associate Professor, Department of Diagnostic Radiology, School of Clinical Medicine, HKUMed 

HKU_LKS Faculty of Medicine_Master Full Logo_Black.png
CNC web logo_footer logo 2.png

Clinical Neuroscience Consortium

bottom of page